What does it do? Acetyl-L-carnitine is similar in form to the amino acid L-carnitine and also has some similar functions, such as being involved in the metabolism of food into energy.
The acetyl group that is part of acetyl-L-carnitine contributes to the production of the neurotransmitter acetylcholine, which is required for mental function. Several double-blind clinical trials suggest that acetyl-L-carnitine delays the progression of Alzheimer’s disease 1 2 and enhances overall performance in some people with Alzheimer’s disease.3 Alzheimer’s research has been done with the acetyl-L-carnitine form, rather than the L-carnitine form, of this nutrient.
One double-blind trial4 has found that acetyl-L-carnitine may be helpful for people with degenerative cerebellar ataxia, a loss of muscular coordination caused by disease in the cerebellum (the hind part of the brain that controls muscle tone and balance).
Acetyl-L-carnitine has been used in connection with the following conditions (refer to the individual health concern for complete information):
| Rating | Health Concerns |
|---|---|
![]() |
Age-related cognitive decline |
![]() |
Alzheimer’s disease Cerebellar ataxia, degenerative Depression (for elderly people) Down's syndrome |
![]() |
Amenorrhea Male infertility Peripheral neuropathy |
Reliable
and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary studies
suggesting a health benefit or minimal health benefit. An herb is primarily supported by traditional use, or
the herb or supplement has little scientific support and/or minimal health benefit. |
|
Are there any side effects or interactions? Side effects from taking acetyl-L-carnitine are uncommon, although skin rash, increased appetite, nausea, vomiting, agitation, and body odor have been reported in people taking acetyl-L-carnitine.6 7
Are there any drug interactions? Certain medications may interact with acetyl-L-carnitine. Refer to the drug interactions safety check for a list of those medications.
1. Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease. Neurobiol Aging 1995;16:1–4.
2. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer’s disease. Arch Neurol 1992;49:1137–41.
3. Cucinotta D, Passeri M, Ventura S, et al. Multicenter clinical placebo-controlled study with acetyl-L-carnitine (LAC) in the treatment of mildly demented elderly patients. Drug Development Res 1988;14:213–6.
4. Sorbi S, Forleo P, Fani C, Piacentini S. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Clin Neuropharmacol 2000;23:114–8.
5. No authors listed. Acetyl-L-Carnitine. Altern Med Rev 1999;4:438–41 [review].
6. Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer’s disease. Neurology 1996;47:705–11.
7. Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer’s dementia. Curr Med Res Opin 1990;11:638–47.